TY - JOUR
T1 - Second-line FOLFOX chemotherapy for advanced biliary tract cancer
AU - Foo, Tiffany
AU - Kichenadasse, Ganessan
AU - Roy, Amitesh
AU - Karapetis, Christos S.
PY - 2021/7
Y1 - 2021/7
N2 - The ABC-06 trial is an important, prospective, randomised phase 3 clinical trial that examined the role of second-line chemotherapy in advanced biliary tract cancers.1 Angela Lamarca and colleagues randomly assigned 162 patients to active symptom control (ASC) and FOLFOX chemotherapy (folinic acid, fluorouracil, and oxaliplatin) or ASC alone. Although the study met its endpoint, the improvement in overall survival was modest....
AB - The ABC-06 trial is an important, prospective, randomised phase 3 clinical trial that examined the role of second-line chemotherapy in advanced biliary tract cancers.1 Angela Lamarca and colleagues randomly assigned 162 patients to active symptom control (ASC) and FOLFOX chemotherapy (folinic acid, fluorouracil, and oxaliplatin) or ASC alone. Although the study met its endpoint, the improvement in overall survival was modest....
KW - FOLFOX chemotherapy
KW - biliary tract cancer
KW - intrahepatic cholangiocarcinomas
UR - http://www.scopus.com/inward/record.url?scp=85108791658&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(21)00269-2
DO - 10.1016/S1470-2045(21)00269-2
M3 - Letter
AN - SCOPUS:85108791658
SN - 1470-2045
VL - 22
SP - e286
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 7
ER -